Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales264395401484565648
Operating income (EBITDA)-25,210456,075,9113148
Operating profit (EBIT)-33,285,545,169,5124194
Pre-Tax Profit (EBT)-32,985,9-96,4---
Net income-32,985,9-18,1-27,337,967,4
EPS ( $)-0,691,74-0,37-0,710,601,25
Dividend per Share ( $)------
Yield------
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Finances - Leverage
Auxilium Pharmaceuticals,  : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt--246411287146
Finance154157----
Operating income (EBITDA)-25,210456,075,9113148
Leverage
(Debt/EBITDA)
--4,39x5,41x2,54x0,98x
Capital Expenditure6,648,7610,411,912,112,1
Book Value Per Share (BVPS)1,75 $4,06 $5,07 $6,99 $9,14 $11,4 $
Cash Flow per Share0,64 $-0,05 $-0,24 $1,33 $2,07 $2,23 $
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Balance Sheet Analysis
Auxilium Pharmaceuticals,  : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 1 383 M$ -
Company Value 1 794 M$ 1 670 M$
Valuation 2014e 2015e
PER (Price / EPS) 46,2x
Capitalization / Revenue 2,86x 2,45x
EV / Revenue 3,70x 2,96x
EV / EBITDA 23,6x 14,8x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 14,3% 22,0%
operating Leverage (Delta EBIT / Delta Sales) 2,59x 4,75x
Net Margin (Net Profit / Revenue) -5,63% 6,70%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 10,2% 15,0%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   2,45% 2,15%
Cash Flow / Sales (Taux d'autofinancement) 13,8% 18,4%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 5,41x 2,54x
Price Earning Ratio
Auxilium Pharmaceuticals,  : Price Earning Ratio
EPS & Dividend
Auxilium Pharmaceuticals,  : EPS Dividend
Dynamic quotes  
ON
| OFF